Skip to main content
Top
Published in: Arthritis Research & Therapy 3/2010

Open Access 01-06-2010 | Research article

Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts

Authors: Elena Neumann, Birgit Riepl, Anette Knedla, Stephanie Lefèvre, Ingo H Tarner, Joachim Grifka, Jurgen Steinmeyer, Jurgen Schölmerich, Steffen Gay, Ulf Müller-Ladner

Published in: Arthritis Research & Therapy | Issue 3/2010

Login to get access

Abstract

Introduction

Rheumatoid arthritis synovial fibroblasts (RASF) are key players in synovial pathophysiology and are therefore examined extensively in various experimental approaches. We evaluated, whether passaging during culture and freezing has effects on gene expression and cell proliferation.

Methods

RASF were passaged for up to 8 passages. RNA was isolated after each passage and cDNA arrays were performed to evaluate the RNA expression pattern during passaging. In addition, doubling time of the cells was also measured.

Results

From passages 2-4, mRNA expression did not change significantly. Gene expression in RASF started to change in passages 5-6 with 7-10% differentially expressed genes. After passages 7-8, more than 10% of the genes were differentially expressed. The doubling rate was constant for up to 5 passages and decreased after passages 6-8. After freezing, gene expression of the second passage is comparable to gene expression prior to freezing.

Conclusions

The results of this study show, that experiments, which examine gene expression of RASF and shall reflect or imitate an in vivo situation, should be limited to early culture passages to avoid cell culture effects. It is not necessary to stop culturing SF after a few passages, but to keep the problems of cell culture in mind to avoid false positive results. Especially, when large-scale screening methods on mRNA level are used. Of note, freezing does not affect gene expression substantially.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gay S, Gay RE, Koopman WJ: Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?. Ann Rheum Dis. 1993, 52 (Suppl 1): S39-S47. 10.1136/ard.52.Suppl_1.S39.PubMedCentralCrossRefPubMed Gay S, Gay RE, Koopman WJ: Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction?. Ann Rheum Dis. 1993, 52 (Suppl 1): S39-S47. 10.1136/ard.52.Suppl_1.S39.PubMedCentralCrossRefPubMed
2.
go back to reference Muller-Ladner U, Gay RE, Gay S: Molecular biology of cartilage and bone destruction. Curr Opin Rheumatol. 1998, 10: 212-219. 10.1097/00002281-199805000-00010.CrossRefPubMed Muller-Ladner U, Gay RE, Gay S: Molecular biology of cartilage and bone destruction. Curr Opin Rheumatol. 1998, 10: 212-219. 10.1097/00002281-199805000-00010.CrossRefPubMed
3.
go back to reference Firestein GS: Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?. Arthritis Rheum. 1996, 39: 1781-1790. 10.1002/art.1780391103.CrossRefPubMed Firestein GS: Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?. Arthritis Rheum. 1996, 39: 1781-1790. 10.1002/art.1780391103.CrossRefPubMed
4.
go back to reference Pap T, Muller-Ladner U, Gay RE, Gay S: Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2000, 2: 361-367. 10.1186/ar113.PubMedCentralCrossRefPubMed Pap T, Muller-Ladner U, Gay RE, Gay S: Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2000, 2: 361-367. 10.1186/ar113.PubMedCentralCrossRefPubMed
5.
go back to reference Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, Gay S: Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol. 1996, 149: 1607-1615.PubMedCentralPubMed Muller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, Gay S: Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol. 1996, 149: 1607-1615.PubMedCentralPubMed
6.
go back to reference Kullmann F, Judex M, Ballhorn W, Justen HP, Wessinghage D, Welsh J, Yen TJ, Lang B, Hittle JC, McClelland M, Gay S, Schölmerich J, Müller-Ladner U: Kinesin-like protein CENP-E is upregulated in rheumatoid synovial fibroblasts. Arthritis Res. 1999, 1: 71-80. 10.1186/ar13.PubMedCentralCrossRefPubMed Kullmann F, Judex M, Ballhorn W, Justen HP, Wessinghage D, Welsh J, Yen TJ, Lang B, Hittle JC, McClelland M, Gay S, Schölmerich J, Müller-Ladner U: Kinesin-like protein CENP-E is upregulated in rheumatoid synovial fibroblasts. Arthritis Res. 1999, 1: 71-80. 10.1186/ar13.PubMedCentralCrossRefPubMed
7.
go back to reference Aicher WK, Heer AH, Trabandt A, Bridges SL, Schroeder HW, Stransky G, Gay RE, Eibel H, Peter HH, Siebenlist U, et al: Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patients. J Immunol. 1994, 152: 5940-5948.PubMed Aicher WK, Heer AH, Trabandt A, Bridges SL, Schroeder HW, Stransky G, Gay RE, Eibel H, Peter HH, Siebenlist U, et al: Overexpression of zinc-finger transcription factor Z-225/Egr-1 in synoviocytes from rheumatoid arthritis patients. J Immunol. 1994, 152: 5940-5948.PubMed
8.
go back to reference Rutkauskaite E, Zacharias W, Schedel J, Muller-Ladner U, Mawrin C, Seemayer CA, Alexander D, Gay RE, Aicher WK, Michel BA, Gay S, Pap T: Ribozymes that inhibit the production of matrix metalloproteinase 1 reduce the invasiveness of rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2004, 50: 1448-1456. 10.1002/art.20186.CrossRefPubMed Rutkauskaite E, Zacharias W, Schedel J, Muller-Ladner U, Mawrin C, Seemayer CA, Alexander D, Gay RE, Aicher WK, Michel BA, Gay S, Pap T: Ribozymes that inhibit the production of matrix metalloproteinase 1 reduce the invasiveness of rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2004, 50: 1448-1456. 10.1002/art.20186.CrossRefPubMed
9.
go back to reference Seki T, Selby J, Haupl T, Winchester R: Use of differential subtraction method to identify genes that characterize the phenotype of cultured rheumatoid arthritis synoviocytes. Arthritis Rheum. 1998, 41: 1356-1364. 10.1002/1529-0131(199808)41:8<1356::AID-ART4>3.0.CO;2-X.CrossRefPubMed Seki T, Selby J, Haupl T, Winchester R: Use of differential subtraction method to identify genes that characterize the phenotype of cultured rheumatoid arthritis synoviocytes. Arthritis Rheum. 1998, 41: 1356-1364. 10.1002/1529-0131(199808)41:8<1356::AID-ART4>3.0.CO;2-X.CrossRefPubMed
10.
go back to reference Neumann E, Judex M, Kullmann F, Grifka J, Robbins PD, Pap T, Gay RE, Evans CH, Gay S, Scholmerich J, Müller-Ladner U: Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway. Gene Ther. 2002, 9: 1508-1519. 10.1038/sj.gt.3301811.CrossRefPubMed Neumann E, Judex M, Kullmann F, Grifka J, Robbins PD, Pap T, Gay RE, Evans CH, Gay S, Scholmerich J, Müller-Ladner U: Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway. Gene Ther. 2002, 9: 1508-1519. 10.1038/sj.gt.3301811.CrossRefPubMed
11.
go back to reference Neumann E, Kullmann F, Judex M, Justen HP, Wessinghage D, Gay S, Scholmerich J, Muller-Ladner U: Identification of differentially expressed genes in rheumatoid arthritis by a combination of complementary DNA array and RNA arbitrarily primed-polymerase chain reaction. Arthritis Rheum. 2002, 46: 52-63. 10.1002/1529-0131(200201)46:1<52::AID-ART10048>3.0.CO;2-1.CrossRefPubMed Neumann E, Kullmann F, Judex M, Justen HP, Wessinghage D, Gay S, Scholmerich J, Muller-Ladner U: Identification of differentially expressed genes in rheumatoid arthritis by a combination of complementary DNA array and RNA arbitrarily primed-polymerase chain reaction. Arthritis Rheum. 2002, 46: 52-63. 10.1002/1529-0131(200201)46:1<52::AID-ART10048>3.0.CO;2-1.CrossRefPubMed
12.
go back to reference Gay S, Gay RE: Cellular basis and oncogene expression of rheumatoid joint destruction. Rheumatol Int. 1989, 9: 105-113.PubMed Gay S, Gay RE: Cellular basis and oncogene expression of rheumatoid joint destruction. Rheumatol Int. 1989, 9: 105-113.PubMed
13.
go back to reference Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR: Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci. 1997, 94: 10895-10900. 10.1073/pnas.94.20.10895.PubMedCentralCrossRefPubMed Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR: Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci. 1997, 94: 10895-10900. 10.1073/pnas.94.20.10895.PubMedCentralCrossRefPubMed
14.
go back to reference Kullmann F, Judex M, Neudecker I, Lechner S, Justen HP, Green DR, Wessinghage D, Firestein GS, Gay S, Scholmerich J, Müller-Ladner U: Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 1999, 42: 1594-1600. 10.1002/1529-0131(199908)42:8<1594::AID-ANR5>3.0.CO;2-#.CrossRefPubMed Kullmann F, Judex M, Neudecker I, Lechner S, Justen HP, Green DR, Wessinghage D, Firestein GS, Gay S, Scholmerich J, Müller-Ladner U: Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 1999, 42: 1594-1600. 10.1002/1529-0131(199908)42:8<1594::AID-ANR5>3.0.CO;2-#.CrossRefPubMed
15.
go back to reference Muller-Ladner U, Kriegsmann J, Gay RE, Gay S: Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Am. 1995, 21: 675-690.PubMed Muller-Ladner U, Kriegsmann J, Gay RE, Gay S: Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Am. 1995, 21: 675-690.PubMed
16.
go back to reference Kraan MC, Haringman JJ, Weedon H, Barg EC, Smith MD, Ahern MJ, Smeets TJ, Breedveld FC, Tak PP: T cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis. Ann Rheum Dis. 2004, 63: 483-488. 10.1136/ard.2003.009225.PubMedCentralCrossRefPubMed Kraan MC, Haringman JJ, Weedon H, Barg EC, Smith MD, Ahern MJ, Smeets TJ, Breedveld FC, Tak PP: T cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis. Ann Rheum Dis. 2004, 63: 483-488. 10.1136/ard.2003.009225.PubMedCentralCrossRefPubMed
17.
go back to reference Tolboom TC, Huidekoper AL, Kramer IM, Pieterman E, Toes RE, Huizinga TW: Correlation between expression of CD44 splice variant v8-v9 and invasiveness of fibroblast-like synoviocytes in an in vitro system. Clin Exp Rheumatol. 2004, 22: 158-164.PubMed Tolboom TC, Huidekoper AL, Kramer IM, Pieterman E, Toes RE, Huizinga TW: Correlation between expression of CD44 splice variant v8-v9 and invasiveness of fibroblast-like synoviocytes in an in vitro system. Clin Exp Rheumatol. 2004, 22: 158-164.PubMed
18.
go back to reference Hashiramoto A, Sano H, Maekawa T, Kawahito Y, Kimura S, Kusaka Y, Wilder RL, Kato H, Kondo M, Nakajima H: C-myc antisense oligodeoxynucleotides can induce apoptosis and down-regulate Fas expression in rheumatoid synoviocytes. Arthritis Rheum. 1999, 42: 954-962. 10.1002/1529-0131(199905)42:5<954::AID-ANR14>3.0.CO;2-J.CrossRefPubMed Hashiramoto A, Sano H, Maekawa T, Kawahito Y, Kimura S, Kusaka Y, Wilder RL, Kato H, Kondo M, Nakajima H: C-myc antisense oligodeoxynucleotides can induce apoptosis and down-regulate Fas expression in rheumatoid synoviocytes. Arthritis Rheum. 1999, 42: 954-962. 10.1002/1529-0131(199905)42:5<954::AID-ANR14>3.0.CO;2-J.CrossRefPubMed
19.
go back to reference Muller-Ladner U, Judex M, Justen HP, Wessinghage D, Welsh J, McClelland M, Gay S, Scholmerich J, Kullmann F: Analysis of gene expression patterns in rheumatoid synovial fibroblasts using RAP-PCR for differential display. Med Klin. 1999, 94: 228-232. 10.1007/BF03044860.CrossRef Muller-Ladner U, Judex M, Justen HP, Wessinghage D, Welsh J, McClelland M, Gay S, Scholmerich J, Kullmann F: Analysis of gene expression patterns in rheumatoid synovial fibroblasts using RAP-PCR for differential display. Med Klin. 1999, 94: 228-232. 10.1007/BF03044860.CrossRef
20.
go back to reference Mathieu-Daude F, Cheng R, Welsh J, McClelland M: Screening of differentially amplified cDNA products from RNA arbitrarily primed PCR fingerprints using single strand conformation polymorphism (SSCP) gels. Nucleic Acids Res. 1996, 24: 1504-1507. 10.1093/nar/24.8.1504.PubMedCentralCrossRefPubMed Mathieu-Daude F, Cheng R, Welsh J, McClelland M: Screening of differentially amplified cDNA products from RNA arbitrarily primed PCR fingerprints using single strand conformation polymorphism (SSCP) gels. Nucleic Acids Res. 1996, 24: 1504-1507. 10.1093/nar/24.8.1504.PubMedCentralCrossRefPubMed
21.
go back to reference Vogt TM, Welsh J, Stolz W, Kullmann F, Jung B, Landthaler M, McClelland M: RNA fingerprinting displays UVB-specific disruption of transcriptional control in human melanocytes. Cancer Res. 1997, 57: 3554-3561.PubMed Vogt TM, Welsh J, Stolz W, Kullmann F, Jung B, Landthaler M, McClelland M: RNA fingerprinting displays UVB-specific disruption of transcriptional control in human melanocytes. Cancer Res. 1997, 57: 3554-3561.PubMed
22.
go back to reference Trenkle T, Welsh J, McClelland M: Differential display probes for cDNA arrays. Biotechniques. 1999, 27: 554-60. 562, 564PubMed Trenkle T, Welsh J, McClelland M: Differential display probes for cDNA arrays. Biotechniques. 1999, 27: 554-60. 562, 564PubMed
23.
go back to reference Masuda K, Masuda R, Neidhart M, Simmen BR, Michel BA, Muller-Ladner U, Gay RE, Gay S: Molecular profile of synovial fibroblasts in rheumatoid arthritis depends on the stage of proliferation. Arthritis Res. 2002, 4: R8-10.1186/ar427.PubMedCentralCrossRefPubMed Masuda K, Masuda R, Neidhart M, Simmen BR, Michel BA, Muller-Ladner U, Gay RE, Gay S: Molecular profile of synovial fibroblasts in rheumatoid arthritis depends on the stage of proliferation. Arthritis Res. 2002, 4: R8-10.1186/ar427.PubMedCentralCrossRefPubMed
24.
go back to reference Schedel J, Seemayer CA, Pap T, Neidhart M, Kuchen S, Michel BA, Gay RE, Muller-Ladner U, Gay S, Zacharias W: Targeting cathepsin L (CL) by specific ribozymes decreases CL protein synthesis and cartilage destruction in rheumatoid arthritis. Gene Ther. 2004, 11: 1040-1047. 10.1038/sj.gt.3302265.CrossRefPubMed Schedel J, Seemayer CA, Pap T, Neidhart M, Kuchen S, Michel BA, Gay RE, Muller-Ladner U, Gay S, Zacharias W: Targeting cathepsin L (CL) by specific ribozymes decreases CL protein synthesis and cartilage destruction in rheumatoid arthritis. Gene Ther. 2004, 11: 1040-1047. 10.1038/sj.gt.3302265.CrossRefPubMed
25.
go back to reference Fiehn C, Neumann E, Wunder A, Krienke S, Gay S, Muller-Ladner U: Methotrexate (MTX) and albumin coupled with MTX (MTX-HSA) suppress synovial fibroblast invasion and cartilage degradation in vivo. Ann Rheum Dis. 2004, 63: 884-886. 10.1136/ard.2003.013748.PubMedCentralCrossRefPubMed Fiehn C, Neumann E, Wunder A, Krienke S, Gay S, Muller-Ladner U: Methotrexate (MTX) and albumin coupled with MTX (MTX-HSA) suppress synovial fibroblast invasion and cartilage degradation in vivo. Ann Rheum Dis. 2004, 63: 884-886. 10.1136/ard.2003.013748.PubMedCentralCrossRefPubMed
26.
go back to reference Muller-Ladner U, Elices MJ, Kriegsmann JB, Strahl D, Gay RE, Firestein GS, Gay S: Alternatively spliced CS-1 fibronectin isoform and its receptor VLA-4 in rheumatoid arthritis synovium. J Rheumatol. 1997, 24: 1873-1880.PubMed Muller-Ladner U, Elices MJ, Kriegsmann JB, Strahl D, Gay RE, Firestein GS, Gay S: Alternatively spliced CS-1 fibronectin isoform and its receptor VLA-4 in rheumatoid arthritis synovium. J Rheumatol. 1997, 24: 1873-1880.PubMed
27.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002/art.1780310302.CrossRefPubMed Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002/art.1780310302.CrossRefPubMed
28.
go back to reference Neumann E, Lechner S, Tarner IH, Grifka J, Gay S, Ruschoff J, Renke B, Scholmerich J, Kullmann F, Muller-Ladner U: Evaluation of differentially expressed genes by a combination of cDNA array and RAP-PCR using the AtlasImage 2.0 software. J Autoimmun. 2003, 21: 161-166. 10.1016/S0896-8411(03)00088-X.CrossRefPubMed Neumann E, Lechner S, Tarner IH, Grifka J, Gay S, Ruschoff J, Renke B, Scholmerich J, Kullmann F, Muller-Ladner U: Evaluation of differentially expressed genes by a combination of cDNA array and RAP-PCR using the AtlasImage 2.0 software. J Autoimmun. 2003, 21: 161-166. 10.1016/S0896-8411(03)00088-X.CrossRefPubMed
29.
go back to reference Mangasser-Stephan K, Dooley S, Welter C, Mutschler W, Hanselmann RG: Identification of human semaphorin E gene expression in rheumatoid synovial cells by mRNA differential display. Biochem Biophys Res Commun. 1997, 234: 153-156. 10.1006/bbrc.1997.6607.CrossRefPubMed Mangasser-Stephan K, Dooley S, Welter C, Mutschler W, Hanselmann RG: Identification of human semaphorin E gene expression in rheumatoid synovial cells by mRNA differential display. Biochem Biophys Res Commun. 1997, 234: 153-156. 10.1006/bbrc.1997.6607.CrossRefPubMed
30.
go back to reference Muller-Ladner U, Kriegsmann J, Tschopp J, Gay RE, Gay S: Demonstration of granzyme A and perforin messenger RNA in the synovium of patients with rheumatoid arthritis. Arthritis Rheum. 1995, 38: 477-484. 10.1002/art.1780380404.CrossRefPubMed Muller-Ladner U, Kriegsmann J, Tschopp J, Gay RE, Gay S: Demonstration of granzyme A and perforin messenger RNA in the synovium of patients with rheumatoid arthritis. Arthritis Rheum. 1995, 38: 477-484. 10.1002/art.1780380404.CrossRefPubMed
31.
go back to reference Dimri GP, Campisi J: Altered profile of transcription factor-binding activities in senescent human fibroblasts. Exp Cell Res. 1994, 212: 132-140. 10.1006/excr.1994.1127.CrossRefPubMed Dimri GP, Campisi J: Altered profile of transcription factor-binding activities in senescent human fibroblasts. Exp Cell Res. 1994, 212: 132-140. 10.1006/excr.1994.1127.CrossRefPubMed
32.
go back to reference Pap T, Franz JK, Hummel KM, Jeisy E, Gay R, Gay S: Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res. 2000, 2: 59-64. 10.1186/ar69.PubMedCentralCrossRefPubMed Pap T, Franz JK, Hummel KM, Jeisy E, Gay R, Gay S: Activation of synovial fibroblasts in rheumatoid arthritis: lack of expression of the tumour suppressor PTEN at sites of invasive growth and destruction. Arthritis Res. 2000, 2: 59-64. 10.1186/ar69.PubMedCentralCrossRefPubMed
33.
go back to reference Rinaldi N, Schwarz-Eywill M, Weis D, Leppelmann-Jansen P, Lukoschek M, Keilholz U, Barth TF: Increased expression of integrins on fibroblast-like synoviocytes from rheumatoid arthritis in vitro correlates with enhanced binding to extracellular matrix proteins. Ann Rheum Dis. 1997, 56: 45-51. 10.1136/ard.56.1.45.PubMedCentralCrossRefPubMed Rinaldi N, Schwarz-Eywill M, Weis D, Leppelmann-Jansen P, Lukoschek M, Keilholz U, Barth TF: Increased expression of integrins on fibroblast-like synoviocytes from rheumatoid arthritis in vitro correlates with enhanced binding to extracellular matrix proteins. Ann Rheum Dis. 1997, 56: 45-51. 10.1136/ard.56.1.45.PubMedCentralCrossRefPubMed
Metadata
Title
Cell culture and passaging alters gene expression pattern and proliferation rate in rheumatoid arthritis synovial fibroblasts
Authors
Elena Neumann
Birgit Riepl
Anette Knedla
Stephanie Lefèvre
Ingo H Tarner
Joachim Grifka
Jurgen Steinmeyer
Jurgen Schölmerich
Steffen Gay
Ulf Müller-Ladner
Publication date
01-06-2010
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 3/2010
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3010

Other articles of this Issue 3/2010

Arthritis Research & Therapy 3/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.